Bionano_RGB.png
Bionano Genomics’ Structural Variation Data Featured In Many Scientific Presentations at the ASHG 2017 Annual Meeting
October 09, 2017 08:00 ET | Bionano Genomics
SAN DIEGO, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Bionano Genomics, the structural variation company, announces a series of presentations at the upcoming American Society of Human Genetics (ASHG) Annual...
logo_centered_440x386.png
Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting
October 03, 2017 07:30 ET | Pacific Biosciences, Inc.
MENLO PARK, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that the human genetics community is demonstrating increasing recognition...
Tempus.jpg
Tempus and the OHSU Knight Cancer Institute Collaborating on Personalized Medicine Data Initiative
September 28, 2017 10:00 ET | Tempus
CHICAGO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...
optalysys_logo-163x49@2x.png
Optalysys, Ltd. Raises $4 Million Seed Round to Break Bottlenecks in Genomic Research and Big Data Analysis
September 20, 2017 09:00 ET | Optalysys Ltd.
GLASSHOUGHTON, WEST YORKSHIRE, United Kingdom and RENO, Nev., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Optalysys Ltd. (@Optalysys), a start-up pioneering the development of light-speed optical...
Bionano_RGB.png
Bionano Genomics Announces Inversion Detection Algorithms With Unmatched Sensitivity
September 05, 2017 08:00 ET | Bionano Genomics
SAN DIEGO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Bionano Genomics®, Inc., a company focused on genome structure analysis, today released updated algorithms, analysis tools and visualization software...
Telemynd.png
MYnd Analytics Invited to Present Updated Data at Military Research Symposium
August 29, 2017 07:30 ET | MYnd Analytics, Inc.
MISSION VIEJO, Calif., Aug. 29, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive medicine company which brings objective physical findings to psychiatric treatment in order...
17_OmniSeq_CorporateLogo_RGB.png
OmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding Commitment
August 21, 2017 08:01 ET | OmniSeq
BUFFALO, N.Y., Aug. 21, 2017 (GLOBE NEWSWIRE) -- OmniSeq, Inc., a molecular diagnostics subsidiary of the Roswell Park Cancer Institute, announced today that it has entered into an exclusive...
SBT_New August 2022 LOGO
Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System
August 17, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a...
Telemynd.png
MYnd Analytics, Horizon Healthcare Services, Inc., Hackensack Meridian Health and Cota Inc., Announce Collaboration to Demonstrate Clinical Utility and Cost Savings When Utilizing the Peer Online®
August 16, 2017 07:30 ET | MYnd Analytics, Inc.
MISSION VIEJO, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive analytics company which brings objective physical findings to psychiatric treatment,...
LETTER TO SHAREHOLDERS: MYnd Analytics Inc.
MYnd Analytics, Inc. Letter to Shareholders
August 15, 2017 10:37 ET | MYnd Analytics, Inc.
MISSION VIEJO, Calif, Aug. 15, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND) To our shareholders: Predictive medicine is one of the fastest-growing markets in healthcare, with...